DEHP: The Phthalate in Food Packaging and Everyday Products

DEHP is the highest-volume phthalate on earth — roughly 3 million tonnes produced globally per year, making DEHP the single most manufactured phthalate produced per year. It's in food packaging, vinyl flooring, shower curtains, car interiors, cable insulation, and medical devices. MEHPMono(2-ethylhexyl) phthalate — the primary urinary metabolite of DEHP. Detected in 78% of the US population in NHANES biomonitoring., its primary metabolite, has been detected in 78% of the US population had detectable DEHP metabolites in NHANES 1999-2000 biomonitoring of the US population Kato et al. 2004. DEHP is the single member of the phthalate family you're most likely carrying — and this article covers the exposure route nobody outside a hospital thinks about.

DEHP — di(2-ethylhexyl) phthalate, CAS 117-81-7 — is a synthetic ester of phthalic acid that has been the dominant PVC plasticiser since the 1930s. It constitutes 50%+ of all plasticiser production globally — DEHP is to PVC what sugar is to baking of global plasticiser production. Wherever you see flexible PVC — the shower curtain that drapes instead of cracking, the cable that bends instead of snapping, the blood bag that squeezes instead of shattering — DEHP is almost certainly the reason. The molecule isn't chemically bonded to the PVC chain. It sits between the polymer strands like oil between gears, and it migrates out whenever heat, fat, or time gives it the opportunity.

That migration is the exposure route. Hot food in plastic wrap. A stored blood bag leaching DEHP into the blood inside it. A premature infant's IV line delivering plasticiser along with the medication. The chemical was designed to leave the plastic. It does exactly what it was designed to do — and the destinations include your food and your bloodstream.

For most adults, the dominant route is food — specifically food that has been stored, heated, or wrapped in flexible PVC. Five families who switched from their normal diet to fresh food for three days — nothing from cans or plastic packaging — dropped DEHP metabolites by 53-56% geometric mean reduction in urinary DEHP metabolites after 3 days on fresh food, with maximum reductions of 93-96% Rudel et al. 2011. When they went back to their normal food, levels rebounded within days. Three days to drop by half. Three days back to where you started. The body clears DEHP in hours — the exposure is what's constant.

This is the part of the DEHP story that most consumer articles don't cover, and it's the part the NTPNational Toxicology Program — a US federal interagency program that evaluates chemicals for potential health effects. flagged with the highest concern. Neonatal intensive care units run on PVC. IV lines, feeding tubes, endotracheal tubes, ECMOExtracorporeal membrane oxygenation — a life-support system that pumps blood through an external oxygenator. Used for critically ill newborns with heart or lung failure. The circuit requires extensive PVC tubing. circuits, blood transfusion bags — all flexible PVC, all containing DEHP, all in continuous contact with fluids that go directly into the bloodstream of a newborn.

Fifty-four neonates across two level III NICUs were enrolled in the first study to measure what that meant. Researchers categorised each infant by device intensity — low, medium, or high — based on how many DEHP-containing products were touching their bodies at any given time. Then they measured urinary MEHP. The gradient was clean: low-exposure infants had a median of 4 ng/mL. High-exposure infants — the ones on ventilators, central lines, multiple IV infusions — had 86 ng/mL median urinary MEHP in high-exposure NICU infants — 5.1 times the low-exposure group, a 5.1× difference Green et al. 2005. A follow-up using oxidative metabolites — better biomarkers, impossible to generate from sample contamination — confirmed the pattern at 13-14× the low-exposure levels Weuve et al. 2006.

The NTP-CERHR monograph on DEHP — the foundational governmental risk assessment for this chemical — graduated its concern by exposure level. For adults at typical dietary exposures of 1-30 µg/kg/day: 'minimal concern.' For male infants undergoing intensive medical treatment at exposures up to 6,000 µg/kg/day roughly 200 times the upper end of typical adult dietary exposure: 'serious concern' NTP-CERHR 2006.

A 2021 study put those numbers to the test. Researchers in a French NICU enrolled 104 neonates and measured the plasticiser metabolites in their urine while tracking every medical device connected to each infant — every IV line, every feeding tube, every circuit. For infants on ECMO — the life-support system that pumps a newborn's blood through an external oxygenator and back, through metres of PVC tubing — DEHP exposure exceeded the derived no-effect level by approximately 1,000×. Three orders of magnitude above what toxicologists consider the threshold of concern. The study also detected alternative plasticisers (DINCH, DEHT) in some device categories, confirming that replacements exist and are already entering clinical use Bernard et al. 2021. The most vulnerable patients, receiving the highest doses, through the most direct route, of a chemical rated 'serious concern' by the agency that evaluates it.

Alternatives exist. DEHTDi(2-ethylhexyl) terephthalate — a non-phthalate plasticiser used as a DEHP replacement in medical devices. Structurally similar to DEHP but with a terephthalate backbone rather than a phthalate one., DINCHDiisononyl cyclohexane-1,2-dicarboxylate — a non-phthalate plasticiser developed specifically as a DEHP replacement for sensitive applications including food contact and medical devices., and TOTMTrioctyl trimellitate — a plasticiser used in blood bags and medical tubing as a DEHP alternative. Higher molecular weight reduces migration. are all commercially available non-phthalate plasticisers approved for medical devices. The EU has banned DEHP from medical devices effective July 2030, with authorisation applications required by January 2029. The US FDA recommends labelling and alternatives for high-risk populations — neonates, pregnant women — but has not banned DEHP from medical devices.

DEHP's metabolite MEHP detected in 78% of US adults — a near-universal exposure suppresses testosterone production in fetal Leydig cells by downregulating the steroidogenic enzymes that build testosterone from cholesterol — specifically StARSteroidogenic acute regulatory protein — the rate-limiting transport protein that moves cholesterol into the mitochondria, where testosterone synthesis begins. DEHP reduces its expression. and P450scc, the rate-limiting steps in the synthesis chain Borch et al. 2006. This is mechanistically different from classical anti-androgens like flutamide, which block the androgen receptor directly. DEHP doesn't block the receptor — it reduces the amount of hormone that gets made in the first place. Less testosterone produced during the masculinisation programming windowA critical period during fetal development when testosterone directs the formation of male reproductive anatomy. Insufficient testosterone during this window produces measurable changes at birth. means altered development that shows up at birth.

An important nuance carried from the phthalates overview: in the most-cited human study on phthalates and male reproductive development, DEHP's hydrolytic metabolite MEHP showed no significant association with reduced anogenital distance — p = 0.833 Swan et al. 2005. The phthalate metabolites that DID show effects (MBP, MiBP, MEP) came from personal care products, not food packaging. A later meta-analysis found summed DEHP oxidative metabolites significant for this endpoint — suggesting MEHP alone is an imperfect biomarker, not that DEHP is harmless. The animal evidence for DEHP reproductive toxicity is robust. The human evidence for DEHP specifically is weaker than for DBP and DiBP at the AGD endpoint but stronger through medical device exposure, where the doses are orders of magnitude higher.

DEHP clears the body in hours — like all phthalates, the problem is daily re-exposure, not accumulation. What you buy this week determines your level next week. The eso-friendly framework applies directly: the mechanism for harm is established, the evidence is consistent, and glass containers cost about the same.

Go back to the cling film. You pressed it over a bowl of hot food, and it clung — because DEHP made the PVC flexible enough to stretch and stick. The same property that makes it useful in your kitchen makes it mobile: DEHP isn't bonded to the plastic, so it migrates into whatever the plastic touches. Hot food. Stored blood. A premature baby's IV fluid.

The NTP rated that last scenario 'serious concern' — the highest level of alarm the agency uses for a non-cancer endpoint. The EU responded with a 2030 ban on DEHP in medical devices. The US responded with a labelling recommendation. In your kitchen, the alternative is simpler than either: glass doesn't need a plasticiser, because glass was never rigid PVC in the first place.